Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-22

Clinical Trial Update: Immediate Therapeutic Effects of Diquafosol and Rebamipide in Dry Eye Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the immediate therapeutic effects of Diquafosol and Rebamipide in Dry Eye Disease has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Diquafosol (diquafosol tetrasodium)
  • Rebamipide (rebamipide)

Snippet

Sponsor: Korea University Anam Hospital | Conditions: Dry Eye Disease (DED) | Phase 4 | Status: COMPLETED